Globus Medical, Inc.

GMED: NYSE
66Total

Lowest reading is at 38 out of 100. All scores are out of 100.

About The Company

CEO

Mr. Keith W. Pfeil

Market Cap

10.01 Billion USD

Sector

Healthcare

Website

https://www.globusmedical.com

Last Update

27/09/2026, 17:37:21

Description

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Read More

Strongest readings

  • ✔Altman-Z score of 9.37 sits above the distress range
  • ✔Financial health is strong (health score 96 out of 100)
  • ✔Debt is low at 0.02 times equity
  • ✔Price-to-earnings of 18.8 is below the market average of 19.6

Weakest readings

  • ✘The current price sits above estimated fair value (margin of safety -42.78%)
  • ✘Earnings and cashflow growth is weak (growth score 38 out of 100)
  • ✘Share count has been rising at 1.45% per year

Key Figures

StatusMetricValueReadingMarket avg
✔
Price / earnings (TTM)
18.82x
19.60x
✘
Margin of safety (DCF)
-42.78%
17.95%
✘
Revenue growth (5y average)
3.92%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✘
Share count, per year
1.45%
0.00%
✘Return on capital employed3.90%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

85 / 100

Priced at or below the market on most measures.

StatusMetricValueReadingMarket avg
✔
Price / earnings
18.82x
19.60x
✔Free cashflow yield9.07%
4.70%
✔Price / earnings growth0.87x
1.50x
Price / book1.75x
—
✘
Margin of safety
-42.78%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 42.64 USD is below the current price of 74.52 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: 53.4 USD ✘

Current Price: 74.5 USD

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

38 / 100

Growing more slowly than the market on most measures.

StatusMetricValueReadingMarket avg
✘
Revenue growth
3.92%
10.97%
✔Earnings growth14.63%
14.48%
✘Cashflow growth1.81%
12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Revenue growth has improved this year (19.74% against a five year average of 3.92%)
  • ✔Earnings growth has improved this year (50.83% against a five year average of 14.63%)
  • ✔Free cashflow growth has improved this year

Health

96 / 100

Balance sheet covers its obligations.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✔Altman-Z score9.37
3.00
✔Piotroski score8.00
5.00
✔Debt / equity0.02x
0.80x
✔Current ratio4.62x
1.00x
Interest coverageN/A2.50x
✔Free cashflow / debt1.59x
0.15x
✔Debt / capital0.02x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Management

    47 / 100

    Returns on capital are below the market.

    StatusMetricValueReadingMarket avg
    ✘Return on equity3.18%
    15.00%
    ✘Return on capital employed3.90%
    10.00%
    Return on assets2.76%
    —
    Free cashflow return on capital3.53%
    —
    ✔Return on capital, 5y change1.07%
    0.00%
    ✘
    Share count, per year
    1.45%
    0.00%
    ✔Share count, recent-17.19%
    0.00%
    ✘Realized buyback return-75.70%
    0.00%
    ✔Goodwill erosion / equity0.50%
    2.00%
    Price volatility, 5 year38.06%
    —

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    • ✘New shares were issued while the value score was 85 out of 100

    Analysts

    not enough data
    StatusMetricValueReadingNeutral
    Analyst opinion scoreN/A50

    The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

    Financial History

    Annual figures across the full reporting history we hold.

    Market Peers

    GMED

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    See 35+ Years Annual Reports

    Other Information

    Company Name

    Globus Medical, Inc.

    Currency

    USD

    Beta

    0.956

    Vol Avg

    1550946

    Ceo

    Mr. Keith W. Pfeil

    Cik

    0001237831

    Cusip

    Exchange

    NYSE

    Full Time Employees

    6000

    Industry

    Medical Devices

    Sector

    Healthcare

    Ipo Date

    Address

    2560 General Armistead Avenue

    City

    Audubon

    State

    PA

    Country

    United States

    Zip

    19403-5214

    Phone

    610 930 1800

    Analysis Last Updated

    27/09/2026, 17:37:21

    Financial data compiled from SEC EDGAR filings and Yahoo Finance.

    Noticed an error with something on our site?

    Data, not advice. Do your own diligence.

    We Use Cookies